NEW YORK (GenomeWeb News) – DiagnoCure's fiscal third-quarter revenues increased 143 percent year over year, the Quebec City-based cancer diagnostic firm reported after the close of the market on Thursday.

For the three months ended July 31, revenues totaled C$709,754 (US$722,057), compared to C$292,073 a year ago. Revenues from royalty payments slipped to C$142,102 from C$168,273 a year ago as revenues from Gen-Probe, now part of Hologic, decreased to C$136,843 from C$155,024 a year ago as austerity measures in Europe resulted in softness the region, DiagnoCure said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Nature News reports that early users of Oxford Nanopore's hand-held MinIon are giddy about the technology and its uses. 

In Cell this week: Leukemia-like disease in soft-shell clams, mNET-seq method for profiling growing transcrips, and more.

After seeing Rich's image of the DNA double helix structure in 1973, James Watson called Rich and told him that it was the first time in 20 years he'd had a good night's sleep.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.